FXNP1

Across TCGA pan-cancer cohorts, FXNP1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated FXNP1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher FXNP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FXNP1 expression acts as an unfavorable survival marker.

STAD, LUSC, and SARC are the cancer types where FXNP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.365	0.585	<.001	120	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	63	view →
SARC	OS	Tertile	All	0.025	0.843	<.001	36	view →
GBM	OS	Tertile	All	0.156	0.424	.001	18	view →
HNSC	OS	Tertile	IV	0.541	0.733	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

FXNP1–STAD (DFS)

Open the STAD breakdown →